A Form 4 filed on August 27, 2026 reports that Scott C. Brun, a director of Forte Biosciences, Inc. (NASDAQ:FBRX), disposed of all his outstanding stock options and restricted stock units on August 27, 2026 in connection with a merger transaction.
Robert S. Smith Jr., Executive Vice President and President of Specialty and Furniture, Flooring & Textile Products at Leggett & Platt Inc. (NYSE:LEG), filed a Form 4 on August 27, 2026, reporting changes in beneficial ownership tied to the company's merger with Somnigroup International …
Director Steven Kornfeld filed a Form 4 with the SEC on August 27, 2026, reporting the disposition of all directly held common stock, stock options, and restricted stock units in Forte Biosciences, Inc. (NASDAQ:FBRX) following the completion of a merger with argenx BV.
A Form 4 filed on August 27, 2026 with the Securities and Exchange Commission discloses that Andrew Gundlach, a director of Welltower Inc. (NYSE:WELL), acquired shares of common stock across two trading days through two trust accounts for which Bleichroeder LP serves as registered …
Amaze Holdings (NYSE:AMZE) is betting that the creator economy and AI-powered commerce tools can turn a small technology company into a meaningful platform for online sellers. The company's ambitions currently sit well ahead of its financials, reflecting the challenge of scaling a nascent business …
Cloudastructure (NASDAQ:CSAI) is posting the kind of growth rates that get a small-cap noticed, and the company is betting that its AI-powered video-surveillance platform is hitting an inflection point. The security-technology firm reported a sharp acceleration in subscription revenue for the second quarter of …
Tammy M. Trent, SVP and Chief Accounting Officer of Leggett & Platt Inc (NYSE:LEG), filed a Form 4 on August 27, 2026, reporting changes in beneficial ownership of common stock and derivative securities stemming from the company's merger with Somnigroup International Inc.
Michael P. Gianoni, President and CEO of Blackbaud Inc., filed a Form 4 with the SEC on August 27, 2026, reporting the sale of 17,000 shares of Blackbaud common stock on August 25, 2026.
Shelia M. Violette, Chief Scientific Officer of Q32 Bio Inc. (NASDAQ:QTTB), filed a Form 4 on August 27, 2026, disclosing the automatic sale of 2,798 shares of common stock on August 25, 2026, to cover tax withholding obligations arising from the vesting of restricted …
Lee Kalowski, CFO and President of Q32 Bio Inc., filed a Form 4 on August 27, 2026, reporting the automatic sale of 3,972 shares of common stock on August 25, 2026, to cover tax withholding obligations tied to the vesting of restricted stock units.